Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,606.42
(
0.13%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 84992

Tuesday, 10/13/2009 8:55:50 AM

Tuesday, October 13, 2009 8:55:50 AM

Post# of 257267

It seems to me that MNTA would have been better off to just go the improvement route and do an NDA/BLA with trials. By now they could have had a product on the market.

A hypothetical Lovenox knockoff approved via the NDA route would not have been automatically substitutable for branded Lovenox and would have needed to be actively marketed, greatly lowering the profit margin of such a product compared to the profit margin of generic Lovenox.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now